Operational and safety protocols for neurologic monoclonal antibodies (mAbs) must be precisely matched to disease biology and operational strategy, including mandatory B‑cell and infection monitoring in multiple sclerosi...
From innovation to implementation: Navigating neurologic monoclonal antibody development
Read the whitepaperMaking sense of the rapidly changing biosimilars landscape
Strategies for adapting and achieving optimal market access
Read the whitepaperBuilding a comparative evidence base using network meta-analysis
Methods, implementation and reporting
Read the whitepaperDownload Global and China biotech survey reports
Two new survey reports of 260+ Global and China-based biotech leaders are ready to download
Get your copy now
AI powered search
Search your Query
Physio
Analyst
biotech
cancer
Home
Please login to download the exclusive content
Featured solutions
EngageAI
Our voice of the customer feedback platform has been enhanced using AI; transforming how we listen, respond, and act on your feedback.
Blended solutions
Bespoke, seamless solutions to meet unique sponsor challenges.
Outcome Measures
A multi-faceted approach to identifying, selecting, and implementing evidence-based measures that matter to patients.
Biotech
ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.
Cardiac Safety Solutions
End-to-end cardiac safety solutions, including ECG, event monitoring, BPM, long-term Holter monitoring, ECHO and MUGA studies.
Early Clinical and Bioanalytical Solutions
Innovative early clinical solutions that will advance your drug development strategy.
Site & Patient Solutions
Transforming recruitment through patient-centric trials and real-world, real-time data.
Market Access
Expertise in mission-critical pricing, market access, and reimbursement.
Specialty Laboratory Solutions
Supporting precision medicine programs across all phases of drug diagnostic co-development.
Videos
ICON overview
ICON is expanding the possibilities of clinical research for customers, partners, and patients.
Biotech
Developing transformative therapies with small & mid-sized biopharma companies requires a flexible approach.
Technology solutions
ICON’s technology solutions are focused on the factors most critical to our customers.
AI @ICON
ICON is harnessing AI with pragmatic, impactful, award winning solutions for a healthier world.
Obesity
ICON has the cross functional expertise to help sponsors overcome the challenges associated with obesity research.
Webinars
Insights into first-in-human study design of oligonucleotide
27 May 2026. Register now.
When patients lead: Breaking barriers in ultra-rare disease drug development
Watch the webinar.
ICH GCP E6(R3): Preparing for global implementation, assessing the impact, risk and requirements of the change
Watch the webinar.
